lenalidomide,rituximab
Not Tagged
['augment,trial', 'lenalidomide', 'fil,veral,12', 'augment,data', 'dance', 'ritux', ' lena', 'nhl', 'lymphoma', 'lymsm', 'imab ']
congress | #ash22 , presents five-year results and overall survival update from the augment trial of r2 vs r-placebo in patients with r/r indolent #nhl. r2 continues to demonstrate superior efficacy, consistent with previous data.
#lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm